1[1]Sapir R, Catane R, Kaufman B, et al. Cancer patient expectations of and communication with oncologists and oncology nurse: The experience of an integrated oncology and palliative care service. Support Care Cancer 2000;8(6): 458 - 63
2[2]Ajaj A, Singh MP, Abdulla AJ. Should elderly patients be told they have cancer?Questionnaire survey of older people. BMJ 2001; 323(7322): 1160
3[3]Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: Results from a large study in UK cancer centres. Br J Cancer 2001; 849(1): 48 -51
4[4]Parker PA, Baile WF, de Moor C, et al. Breaking bad news about cancer: patients preferences for communication.J Clin Oncol 2001; 19(7): 2049 - 56
5[5]Ptacek JT, Ptacek JJ. Patients' perceptions of receiving bad news about cancer. J Clin Oncol 2001; 19(21):4160-4
6[6]Friedman HS. Physician management of dying patients: an exploration. Physician Med 1970; 1 (14): 295 - 305
7[7]Han SW, Chung HY, Han SH. A study on the attitudes toward dying patients. J Korean Neuropsychiar Assoc 1990; 29:1408 - 25
8[8]Followfield LJ, Baum M, Maguire GP. Effects of breast conservation on psycholog icai morbidity associated with diagnosis and treatment of early breast cancer. Br Med J( Clin Res Ed) 1986; 293(6558): 1331 - 4
9[9]Morris B, Abram C, Making H D. The Ethical and Legal Implication of Informed Consent in the Practitioner-Patient Relationship. Washington: United States Superintendent of Documents 1982:119
10[10]Davison BJ, Degner LF, Morgan TR. Information and decision-making preferences of men with prostate cancer. Oncol Nurs Forum 1995; 22 ( 5 ): 1401 - 8
3Chen Jin. The current condition and study progression about the quality of life of rectal cancer patients' postoperation. J Coloproctological Surg 2001;7(3):61 -4.
4Lotze MT, Finn OJ. Recent advance in cellular immunology: implications for immunity to cancer. Immunol Today 1990; 11:190 -3.
5Jackson PA, Green MA, Marks CG, et al. Lymphocyte subsets in infiltration patterns and HLA antigen status in colonic carcinomas and adenomas. Gut 1996; 38:85 -9.
6Gazzenelli RT, Wysocka M, Hieng S, et al. In the absence of endogenous IL-10,mice acute infected with foxoplasma gondii succumb to a lethal immune responds dependent on CD4+ T cells and accompanied by over production of IL-12, IFN-γ and TNF-α. J Immunol 1996; 157:798 - 805.
7Waidmann M, Allemand Y, Lehmann J, et al. Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-gamma and TNF-alpha production. Cut 2002; 50(2): 170 -9.
8Sgadari C, Angiolillo AL, Tostato G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible-10. Blood 1996: 87:3877 - 81.
9Galizia G, Orditura M, Romano C, et al. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 2002; 102(2): 169 -78.
10Micallet MJ, yoshida K, Kawai S, et al. In vivo anti-tumor effects of murine interferon-γ-inducing factor interleukin-18 in wice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol Immunother 1997; 43(2): 361 - 73.
